ICAD 241220 7.50P (ICAD241220P7500) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

ICAD241220P7500

Watchlist

0.00
0.000.00%

15min DelayClose Nov 29 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Express News | ICAD Advances Fight Against Breast Cancer With FDA-Cleared, Next-Generation AI Solutions and a Second-Read AI Partnership With Cascaid Health at Rsna 2024
ReutersNov 26 13:00 ET
ICAD Advances Fight Against Breast Cancer With FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership With Cascaid Health at RSNA 2024
GlobeNewswireNov 26 13:00 ET
Colliers Securities Initiates ICAD Inc(ICAD.US) With Buy Rating, Announces Target Price $3
Moomoo NewsNov 21 13:32 ET · Ratings
Need To Know: Analysts Just Made A Substantial Cut To Their ICAD, Inc. (NASDAQ:ICAD) Estimates
Yahoo FinanceNov 17 07:57 ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
BenzingaNov 14 16:10 ET
iCAD Inc | 10-Q: Q3 2024 Earnings Report
SECNov 14 11:56 ET · Announcements

Comments

Jaguar8

Nov 26 12:29

NEWS

$iCAD Inc (ICAD.US)$
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024
iCAD announces major developments at RSNA 2024, including its FDA-cleared ProFound Detection Version 4.0 and a partnership with Cascaid Health.
The collaboration will launch ProFound Health in Q1 2025, offering AI-powered second-read mammography services to expand access to breast health technology. The new Version 4.0...

Teo knows

Nov 26 12:05

$iCAD Inc (ICAD.US)$ good news

Jaguar8

Apr 11 07:08

$iCAD Inc (ICAD.US)$
NEWS
iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
iCAD, Inc. announces partnership with Densitas and showcases ProFound Cloud at SBI symposium, highlighting advancements in breast cancer detection technology
NASHUA, N.H., April 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will sh...

Jaguar8

Apr 8 15:42

$iCAD Inc (ICAD.US)$
NEWS
iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting

Moomoo AI

Mar 2 08:12

iCAD's subdued revenue growth projections and P/S ratio in line with industry peers could risk shareholders' investments and potential investors might pay an unnecessary premium. The current P/S ratio and share price may not be sustainable if revenue growth doesn't improve.

There's Reason For Concern Over ICAD, Inc.'s (NASDAQ:ICAD) Massive 39% Price Jump